Steven Leonard Chapman - 01 Nov 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Role: CEO AND PRESIDENT, Director
Signature: /s/ Tami Chen, Attorney-in-Fact
Issuer symbol: NTRA
Transactions as of: 01 Nov 2021
Net transactions value: -$698,626
Form type: 4
Filing time: 01 Nov 2021, 21:02:02 UTC
Previous filing: 05 Oct 2021
Next filing: 03 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NTRA	Common Stock	Sale	$9,040	-80	-0.22%	$113.00	37,023	01 Nov 2021	Direct	F1, F2
transaction	NTRA	Common Stock	Sale	$48,264	-420	-1.1%	$114.91	36,603	01 Nov 2021	Direct	F1, F3
transaction	NTRA	Common Stock	Sale	$118,077	-1,017	-2.8%	$116.10	35,586	01 Nov 2021	Direct	F1, F4
transaction	NTRA	Common Stock	Options Exercise	$28,353	+3,052	+8.6%	$9.29^*	38,638	01 Nov 2021	Direct
transaction	NTRA	Common Stock	Options Exercise	$42,243	+2,084	+5.4%	$20.27	40,721	01 Nov 2021	Direct
transaction	NTRA	Common Stock	Sale	$22,602	-200	-0.49%	$113.01	40,521	01 Nov 2021	Direct	F5
transaction	NTRA	Common Stock	Sale	$126,894	-1,106	-2.7%	$114.73	39,415	01 Nov 2021	Direct	F5, F6
transaction	NTRA	Common Stock	Sale	$393,086	-3,389	-8.6%	$115.99	36,026	01 Nov 2021	Direct	F5, F7
transaction	NTRA	Common Stock	Sale	$51,259	-440	-1.2%	$116.50	35,586	01 Nov 2021	Direct	F5, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NTRA	Stock Option (right to buy)	Options Exercise	$0	-3,052	-17%	$0.000000	15,263	01 Nov 2021	Common Stock	3,052	$9.29	Direct	F9
transaction	NTRA	Stock Option (right to buy)	Options Exercise	$0	-2,083	-5.6%	$0.000000	35,417	01 Nov 2021	Common Stock	2,083	$20.27	Direct	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2021,
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.56 to $115.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.60 to $116.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5	The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021.
F6	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.44 to $115.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.45 to $116.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.46 to $116.5950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9	The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
F10	The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.